According to data from Brazil's Federal Revenue Service cited by CNN, more than 76,000 vials, bottles, and other products containing these medications were seized on the border with Paraguay during the first half of 2026. ^[1] Brazilian authorities registered a significant increase in seizures of weight loss products containing semaglutide and tirzepatida on the border with Paraguay. ^[2] Japan has the highest debt-to-GDP ratio in the world, exceeding double the amount the country produces annually. ^[3] The active ingredient Semaglutid, previously available as the injection Ozempic or Wegovy, is now approved in tablet form in Germany. ^[4] Fake Ozempic pens sold online may not contain the active ingredient semaglutide but could instead contain completely different chemicals. ^[5] The Czech State Institute for Drug Control (SÚKL) warns that dangerous packaging for fake Ozempic injections has not yet appeared in official reports from licensed distributors but poses a risk from illegal online sales. ^[6] Semaglutide, a medication used for weight loss, has been introduced as a tablet in Germany, with plans for a similar launch in Austria. ^[7] An analysis by Serasa Experian cited by CNN found that online orders related to GLP-1 medications in Brazil increased 149.3% during the first six months of 2026, rising from 547,249 to over 1.36 million requests. ^[8] The seizure figure during the first half of 2026 is nearly three times higher than the total amount seized during the entire year of 2025. ^[9] Approximately 12 million adults in Germany are classified as having severe obesity. ^[10] Germany is the first European Union country to allow the weight-loss pill. ^[11] Historical cases of similar fake injections have resulted in insulin shock for non-diabetics, causing severe hypoglycemia, convulsions, or unconsciousness. ^[12]